Clinical trials
Terminated Multiple Myeloma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2007 | 1 |
| 2009 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 4 |
| University Health Network, Toronto | 3 |
| Amgen | 2 |
| Pfizer | 2 |
| Teva Branded Pharmaceutical Products R&D LLC | 2 |
| AEterna Zentaris | 1 |
| CRISPR Therapeutics AG | 1 |
| Cleave Biosciences, Inc. | 1 |
| Gilead Sciences | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 25 |
| Recurrence | 10 |
| Hematologic Neoplasms | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Myeloproliferative Disorders | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Graft vs Host Disease | 2 |
| Hodgkin Disease | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lymphoma | 2 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.